Skip to main content
Home
  • About Mainstay
  • About Reactiv8
  • For Clinicians
  • Home
  • Investors
  • News & Events
  • Careers
  • Contact Us
  • EN
  • FR
  • DE
  • NL
  • US
  • AU

Main navigation

  • About Mainstay
    • ABOUT MAINSTAY
    • Board of Directors
    • Leadership Team
    • Quality System Certificates
    • The Challenge
    • Contact Us
  • About Reactiv8
    • What is Chronic Low Back Pain?
    • How Does ReActiv8 Work?
    • Is ReActiv8 Right For Me?
  • For Clinicians
    • ReActiv8 Scientific Background
    • ReActiv8 The Product
    • REACTIV8 CLINICAL STUDIES
    • Contact Us
  • Home
  • Investors
    • OVERVIEW
    • Results and Presentations
      • Results
      • Presentations
      • Annual Reports
    • News
      • Press Releases
      • Regulatory News
    • Governance
      • Corporate Governance
      • Board of Directors
      • Leadership Team
      • Board Committees
      • AGM
      • Documents relating to proposed delisting transaction and related shareholder meetings on 8 May
      • Documents relating to February 2021 EGM
    • Shareholder Information
      • Advisors
      • Analysts
      • PFIC Status
      • Registrar
    • Contact Us
  • News & Events
    • Press Releases
    • News
    • Events
    • Contact Us
  • Careers
    • Careers
  • Contact Us
    • Contact Us

© Copyright 2020 Mainstay Medical Limited. All rights reserved.

Footer menu

  • Site Map
  • Contact Us
  • Impressum
  • Privacy Policy
  • Terms & Conditions
  • Commercial Terms & Conditions

ReActiv8 is CE marked for the treatment of chronic low back pain and available for sale in Europe.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show